Encouragingly, clinical research found that increasing CSF insulin by intranasal administration benefits the cognitive function in AD and mild cognitive impairment (MCI) patients (Craft et al., 2012; Claxton et al., 2013, 2015. The gene discussed is INS; the disease is Alzheimer disease.